{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:02:34Z","timestamp":1790208154591,"version":"4.1.0"},"reference-count":22,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"unspecified","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C16077\/A29186"],"award-info":[{"award-number":["C16077\/A29186"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["bmjph"],"accepted":{"date-parts":[[2026,7,15]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To assess the prevalence, detection, treatment and control of hypertension in England.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cross-sectional analysis of baseline blood pressure measurements from the Our Future Health study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Over 200 enrolment centres across England, 2022\u20132025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>1.4 million adults aged \u226518 years with available clinic blood pressure measurements.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Hypertension was defined according to WHO guidelines as systolic blood pressure (SBP) \u2265140\u2009mm Hg, diastolic blood pressure (DBP) \u226590\u2009mm Hg or self-reported use of antihypertensive medication. Detection was defined as self-reported prior diagnosis by a health professional or reported use of antihypertensive medication. Controlled hypertension was defined as SBP &lt;140\u2009mm Hg and DBP &lt;90\u2009mm Hg among those receiving antihypertensive treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 37.2% of participants had hypertension, with higher age-standardised prevalence in men than women (41.9% vs 28.6%). Prevalence increased markedly with age, from 23% to 73% in men and from 10% to 69% in women at ages 18\u201339\u2009and \u226580 years, respectively. Despite this high burden, 58.8% of individuals with hypertension were undetected. Hypertension was strongly associated with older age, male sex and higher body mass index, but the prevalence remained substantial across all population subgroups. Factors associated with hypertension detection largely mirrored those associated with hypertension, except in individuals with prior cardiovascular disease or diabetes, among whom detection was higher. Among detected participants, antihypertensive treatment was associated with lower odds of uncontrolled blood pressure; however, 50.2% of treated individuals did not achieve blood pressure control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Over one-third of adults in England had hypertension, yet only half of affected individuals were detected and half of those treated achieved blood pressure control. The high prevalence across nearly all population subgroups underscores the need for population-wide prevention strategies alongside targeted treatment of individuals at high cardiovascular risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjph-2025-004815","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:20:15Z","timestamp":1790205615000},"page":"e004815","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Hypertension prevalence, detection, treatment and control among 1.4 million adults in England: a cross-sectional analysis from the Our Future Health study in 2022\u20132025"],"prefix":"10.1136","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6682-2053","authenticated-orcid":false,"given":"Wenyu","family":"Liu","sequence":"first","affiliation":[{"name":"Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8010-2503","authenticated-orcid":false,"given":"Jennifer","family":"Collister","sequence":"additional","affiliation":[{"name":"Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1177-6923","authenticated-orcid":false,"given":"Thomas","family":"Littlejohns","sequence":"additional","affiliation":[{"name":"Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9913-1961","authenticated-orcid":false,"given":"Iain James","family":"Turnbull","sequence":"additional","affiliation":[{"name":"Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9802-8241","authenticated-orcid":false,"given":"Robert","family":"Clarke","sequence":"additional","affiliation":[{"name":"Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David John","family":"Hunter","sequence":"additional","affiliation":[{"name":"Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, UK"},{"name":"School of Public Health Department of Epidemiology, Harvard T H Chan, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"2026092316201361000_4.3.e004815.1","first-page":"S0140","article-title":"Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990\u20132023: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","year":"2025","journal-title":"The Lancet"},{"key":"2026092316201361000_4.3.e004815.2","unstructured":"Institute for Health Metrics and Evaluation . GBD results. Seattle (WA): IHME, University of Washington; 2025. Available: https:\/\/vizhub.healthdata.org\/gbd-results"},{"key":"2026092316201361000_4.3.e004815.3","unstructured":"World Health Organization . Global report on hypertension: the race against a silent killer. Geneva World Health Organization; 2023. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240081062"},{"key":"2026092316201361000_4.3.e004815.4","unstructured":"Office for National Statistics . Risk factors for undiagnosed high blood pressure in england - office for national statistics. London: ONS; 2023. Available: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/healthandwellbeing\/datasets\/riskfactorsforundiagnosedhighbloodpressureinengland"},{"key":"2026092316201361000_4.3.e004815.5","unstructured":"Clinical practice research datalink . About us. London: CPRD; 2024. Available: https:\/\/www.cprd.com\/about-us"},{"key":"2026092316201361000_4.3.e004815.6","unstructured":"NHS Cardiovascular Disease Prevention . CVD prevent. London: NHS England; 2024. Available: https:\/\/www.cvdprevent.nhs.uk"},{"key":"2026092316201361000_4.3.e004815.7","doi-asserted-by":"publisher","DOI":"10.1177\/01410768231206033"},{"key":"2026092316201361000_4.3.e004815.8","unstructured":"Digital NE . Leeds: NHS Digital; NHS Health Check Programme, Patients Recorded as Attending and Not Attending, 2012-13 to 2017-18, 2019. Available: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/nhs-health-check-programme\/2012-13-to-2017-18"},{"key":"2026092316201361000_4.3.e004815.9","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyaf171","article-title":"Cohort Profile: Our Future Health","volume":"54","author":"Cook","year":"2025","journal-title":"Int J Epidemiol"},{"key":"2026092316201361000_4.3.e004815.10","unstructured":"Our Future Health . Programme design and recruitment. London: Our Future Health; 2025. Available: https:\/\/ourfuturehealth.gitbook.io\/our-future-health\/programme\/programme-design-and-recruitment"},{"key":"2026092316201361000_4.3.e004815.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)18466-7"},{"key":"2026092316201361000_4.3.e004815.12","unstructured":"National Institute for Health and Care Excellence . Hypertension in adults: diagnosis and management (ng136). London: NICE; 2019. Available: https:\/\/www.nice.org.uk\/guidance\/ng136\/chapter\/Recommendations#diagnosing-hypertension"},{"key":"2026092316201361000_4.3.e004815.13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41371-020-0357-x","article-title":"Options for the diagnosis of high blood pressure in primary care: a systematic review and economic model","volume":"35","author":"Constanti","year":"2021","journal-title":"J Hum Hypertens"},{"key":"2026092316201361000_4.3.e004815.14","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001461","article-title":"Prevalence and determinants of hypertension control among almost 100 000 treated adults in the UK","volume":"8","author":"Tapela","year":"2021","journal-title":"Open Heart"},{"key":"2026092316201361000_4.3.e004815.15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2025-001556","article-title":"Trends in hypertension prevalence, control, and antihypertensive use in England from 2003 to 2021: insights from annual, nationwide Health Surveys for England","volume":"4","author":"Graham","year":"2025","journal-title":"BMJ Med"},{"key":"2026092316201361000_4.3.e004815.16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-068025","article-title":"Evaluating the clinical effectiveness of the NHS Health Check programme: a prospective analysis in the Genetics and Vascular Health Check (GENVASC) study","volume":"13","author":"Debiec","year":"2023","journal-title":"BMJ Open"},{"key":"2026092316201361000_4.3.e004815.17","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2024-002704","article-title":"Challenge of cardiovascular prevention in primary care: achievement of lifestyle, blood pressure, lipids and diabetes targets for primary prevention in England - results from ASPIRE-3-PREVENT cross-sectional survey","volume":"11","author":"Kotseva","year":"2024","journal-title":"Open Heart"},{"key":"2026092316201361000_4.3.e004815.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080811","article-title":"Sacrificing patient care for prevention: distortion of the role of general practice","volume":"388","author":"Martin","year":"2025","journal-title":"BMJ"},{"key":"2026092316201361000_4.3.e004815.19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.184182"},{"key":"2026092316201361000_4.3.e004815.20","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.jacc.2025.12.091","article-title":"Global Hypertension 2000 to 2020: Trends, Disparities, and Progress in Awareness, Treatment, and Control","volume":"87","author":"O\u2019Connell","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"2026092316201361000_4.3.e004815.21","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(19)31145-6","article-title":"Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys","volume":"394","author":"Zhou","year":"2019","journal-title":"The Lancet"},{"key":"2026092316201361000_4.3.e004815.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01330-1"}],"container-title":["BMJ Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjph-2025-004815","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:20:18Z","timestamp":1790205618000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjpublichealth.bmj.com\/lookup\/doi\/10.1136\/bmjph-2025-004815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9,23]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/bmjph-2025-004815"],"URL":"https:\/\/doi.org\/10.1136\/bmjph-2025-004815","relation":{},"ISSN":["2753-4294"],"issn-type":[{"value":"2753-4294","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}